March 17 (Reuters) - Vitrolife AB VITR.ST :
* UPDATE OF CORONAVIRUS'S IMPACT ON VITROLIFE'S SALES
* VITROLIFE ESTIMATES THAT SALES DURING Q1 WILL BE
APPROXIMATELY
IN LINE WITH LAST YEAR IN LOCAL CURRENCY AND THAT EBITDA MARGIN
WILL AMOUNT TO APPROXIMATELY 33-37 PERCENT
* FURTHERMORE, COMPANY ASSESS THAT Q2 WILL BE SIGNIFICANTLY
NEGATIVELY IMPACTED BY VIRUS OUTBREAK
* AND VITROLIFE EXPECTS A CONTINUOUSLY EXPANDING MARKET,
WHICH IN
MONETARY TERMS IS EXPECTED TO GROW BY 5-10 PER CENT PER YEAR FOR
FORESEEABLE FUTURE
* IT IS DIFFICULT TO ESTIMATE HOW VIRUS OUTBREAK WILL AFFECT
DEMAND FOR IVF TREATMENTS DURING Q2 OTHER THAN THAT IT WILL
LIKELY HAVE A SIGNIFICANT NEGATIVE EFFECT
Source text for Eikon: ID:nWkr1SG5Xx
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))